N-(3-(8-acetamidoquinolin-4-yl)-4-methylphenyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide

ID: ALA3087524

PubChem CID: 76335290

Max Phase: Preclinical

Molecular Formula: C27H23N3O4

Molecular Weight: 453.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1cccc2c(-c3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccnc12

Standard InChI:  InChI=1S/C27H23N3O4/c1-16-6-8-19(30-27(32)18-7-9-24-25(14-18)34-13-12-33-24)15-22(16)20-10-11-28-26-21(20)4-3-5-23(26)29-17(2)31/h3-11,14-15H,12-13H2,1-2H3,(H,29,31)(H,30,32)

Standard InChI Key:  RVLWKMXHZOCOIO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   16.7639  -22.3590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4790  -22.7721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1959  -22.3586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1929  -21.5276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7650  -21.5312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4762  -21.1194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4741  -20.2996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7617  -19.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0499  -20.3073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0554  -21.1258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9058  -21.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6206  -21.5239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3330  -21.1085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3295  -20.2822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6077  -19.8731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8984  -20.2908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0496  -21.5182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7626  -21.1025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4792  -21.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7591  -20.2771    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3429  -21.5426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4783  -22.3370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1940  -22.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1856  -21.0952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9019  -21.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9074  -22.3272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6216  -22.7333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.3349  -22.3178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3294  -21.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6106  -21.0811    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6258  -21.1339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9133  -21.5506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6211  -20.3085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1799  -19.8845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  2  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  6  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 10 21  1  0
 19 22  2  0
 22 23  1  0
 23 26  2  0
 25 24  2  0
 24 19  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 21 31  1  0
 31 32  1  0
 31 33  2  0
 16 34  1  0
M  END

Associated Targets(Human)

MAPK3 Tchem Mitogen-activated protein kinase; ERK1/ERK2 (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K2 Tclin Dual specificity mitogen-activated protein kinase kinase; MEK1/2 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.50Molecular Weight (Monoisotopic): 453.1689AlogP: 5.19#Rotatable Bonds: 4
Polar Surface Area: 89.55Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.48CX Basic pKa: 3.43CX LogP: 4.13CX LogD: 4.13
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.44Np Likeness Score: -1.12

References

1. Koh EJ, El-Gamal MI, Oh CH, Lee SH, Sim T, Kim G, Choi HS, Hong JH, Lee SG, Yoo KH..  (2013)  New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.,  70  [PMID:24128410] [10.1016/j.ejmech.2013.06.060]

Source